Dr Khalid Alammar Urologist Essen

Dr Khalid Alammar Urologist Essen

Dr Khalid Alammar Urologist Essen leads a modern urology practice in the centre of Essen. He and his team deliver diagnostic and treatment services for adults and children. Patients receive expert care for urinary tract issues, male reproductive problems, kidney stones, tumors, and more. We focus on modern methods and personal service.

Services Offered in Urology

Our practice offers a full range of urological services. We treat tumor conditions, urinary stone disease, male genital organ disorders, and incontinence. Here we also provide cancer prevention, pediatric urology, vasectomy, and treatment for erectile dysfunction. We deliver both diagnostics and treatments to each patient.

Diagnostic & Therapeutic Procedures

We use advanced diagnostics like ultrasound, x‑ray imaging, laboratory tests, endoscopy, and functional tests. Treatments include outpatient surgeries, stone removal, vasectomy (non‑scalpel if applicable), and tumor care. We incorporate modern and proven methods for the best outcomes.

Patient Experience & Care Philosophy

At our practice, you always receive personal and friendly care. From reception to examination rooms, staff treat you with respect. We value discretion and trust. Here we explain procedures clearly and answer your questions. We aim to make visits easy and stress‑free.

Practice Location & Hours

Our practice is located at Viehofer Str. 2‑4, 45127 Essen. It lies in the city centre with good access by public transport and some nearby parking (including for people with disabilities). Office hours are:
‑ Monday, Tuesday, Thursday, Friday: 8:00 to 13:30
‑ Wednesday: 8:00 to 12:30 and 13:00 to 18:00 (OP centre)

Your Urologist & Medical Qualifications

Dr Khalid Alammar is certified as a Facharzt für Urologie, with additional expertise in medicated tumor therapy. He has many years of experience, both in clinics abroad and in Germany. He became Facharzt in urology in 2015 and earned the additional qualification “medikamentöse Tumortherapie” in 2019.